Status:
COMPLETED
Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients
Lead Sponsor:
University of Oklahoma
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Sars-CoV2
Covid-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center (SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom Tracker (Insight(T...
Detailed Description
A total of 500 treatment-seeking males and females will be asked to complete daily monitoring of symptoms via smartphone app. Those who screen positive for COVID-19 will be triaged to emergency or non...
Eligibility Criteria
Inclusion
- Demonstrate \> 6th grade English literacy level (i.e., phone based EMAs require \>6th grade literacy)
- Present for care at the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center
- Are currently receiving systemic chemotherapy by intravenous infusion or by orally delivered medication
- Are greater than or equal to 18 years of age
- Are willing and able to complete surveys on their personal smartphone or a study provided smartphone
- Are willing and able to provide informed consent
Exclusion
- None
Key Trial Info
Start Date :
July 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2021
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04397614
Start Date
July 22 2020
End Date
November 12 2021
Last Update
April 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stephenson Cancer Center
Oklahoma City, Oklahoma, United States, 73104